Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab + trastuzumab + vinorelbine in first-line HER2-positive advanced breast cancer (Phase II, two-cohort, open-label)
2011-003308-18Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of pertuzumab in breast cancer, sponsored by Roche. Started Nov 2011; status: completed.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-003308-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003308-18.